LPL Financial LLC Has $2.62 Million Stock Position in HealthEquity, Inc. (NASDAQ:HQY)

LPL Financial LLC lifted its stake in HealthEquity, Inc. (NASDAQ:HQY – Get Rating) by 3.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 42,607 shares of the company’s stock after acquiring an additional 1,363 shares during the period. LPL Financial LLC owned approximately 0.05% of HealthEquity worth $2,618,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also modified their holdings of the company. BlackRock Inc. boosted its stake in HealthEquity by 4.0% during the first quarter. BlackRock Inc. now owns 9,423,008 shares of the company’s stock worth $635,488,000 after buying an additional 358,743 shares in the last quarter. Vanguard Group Inc. boosted its stake in shares of HealthEquity by 0.4% in the 3rd quarter. Vanguard Group Inc. now owns 8,173,889 shares of the company’s stock valued at $549,041,000 after purchasing an additional 31,009 shares in the last quarter. Wasatch Advisors Inc. boosted its stake in shares of HealthEquity by 3.3% in the 1st quarter. Wasatch Advisors Inc. now owns 7,638,935 shares of the company’s stock valued at $515,170,000 after purchasing an additional 244,868 shares in the last quarter. State Street Corp boosted its stake in shares of HealthEquity by 2.8% in the 3rd quarter. State Street Corp now owns 2,671,946 shares of the company’s stock valued at $179,475,000 after purchasing an additional 74,035 shares in the last quarter. Finally, Brown Advisory Inc. boosted its stake in shares of HealthEquity by 12.7% in the 3rd quarter. Brown Advisory Inc. now owns 2,059,396 shares of the company’s stock valued at $138,330,000 after purchasing an additional 232,691 shares in the last quarter. Institutional investors and hedge funds own 99.54% of the company’s stock.

Wall Street Analysts Forecast Growth

HQY has been the topic of several recent analyst reports. Royal Bank of Canada restated an “outperform” rating and issued a $75.00 target price on shares of HealthEquity in a research note on Wednesday, March 22nd. StockNews.com initiated coverage on shares of HealthEquity in a research note on Thursday. They issued a “hold” rating on the stock. Wells Fargo & Company reduced their target price on shares of HealthEquity from $101.00 to $89.00 and set an “overweight” rating on the stock in a research note on Friday, February 3rd. Finally, Deutsche Bank Aktiengesellschaft cut their price target on HealthEquity from $72.00 to $69.00 and set a “buy” rating for the company in a report on Friday, March 24th. Three research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to data from MarketBeat, HealthEquity currently has an average rating of “Moderate Buy” and an average price target of $80.91.

HealthEquity Stock Performance

Shares of NASDAQ:HQY opened at $56.77 on Friday. The stock has a market capitalization of $4.85 billion, a P/E ratio of -183.13, a P/E/G ratio of 2.64 and a beta of 0.79. HealthEquity, Inc. has a 1-year low of $48.86 and a 1-year high of $79.20. The company has a current ratio of 2.92, a quick ratio of 2.92 and a debt-to-equity ratio of 0.48. The business has a 50-day moving average price of $56.16 and a two-hundred day moving average price of $60.67.

HealthEquity (NASDAQ:HQY – Get Rating) last announced its quarterly earnings data on Tuesday, March 21st. The company reported $0.26 earnings per share for the quarter, topping the consensus estimate of $0.20 by $0.06. The firm had revenue of $233.84 million during the quarter, compared to analysts’ expectations of $229.43 million. HealthEquity had a positive return on equity of 3.50% and a negative net margin of 3.03%. Equities analysts predict that HealthEquity, Inc. will post 1.02 earnings per share for the current year.

About HealthEquity

(Get Rating)

HealthEquity, Inc engages in the provision of technology-enabled services for healthcare and spending decisions. The company was founded by Stephen D. Neeleman on September 18, 2002 and is headquartered in Draper, UT.